The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population

被引：0
|
作者：
Pei-Yin Pan
Meei-Shyuan Lee
Chin-Bin Yeh
机构：
[1] Tri-Service General Hospital,Department of Psychiatry
[2] National Defense Medical Center,undefined
[3] School of Public Health,undefined
[4] National Defense Medical Center,undefined
来源：
BMC Psychiatry | / 15卷
关键词：
Schizophrenia; Quetiapine XR; Antipsychotic agents; Drug switching; Chinese population;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] THE EFFECTS OF ONCE-DAILY OPICAPONE 50 MG ON THE PHARMACOKINETICS OF LEVODOPA ADMINISTERED AS CARBIDOPA/LEVODOPA EXTENDED-RELEASE CAPSULES: AN OPEN-LABEL STUDY
    Klepitskaya, O.
    Vijan, A.
    Olson, K.
    O'Reilly, T.
    Liang, G.
    Loewen, G.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 44 - 44
  • [32] ADHD treatment with once-daily OROS® MPH:: A long-term, open-label study of safety and tolerability
    Wolraich, ML
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [33] Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study
    Lee, Eung Chang
    Kim, Seong Hoon
    Park, Sang-Jae
    ANNALS OF TRANSPLANTATION, 2018, 23 : 713 - 720
  • [34] Randomised, placebo-controlled, relapse-prevention study with once-daily quetiapine sustained release in patients with schizophrenia
    Peuskens, J.
    Trivedi, J. K.
    Malyarov, S.
    Brecher, M.
    Svensson, O.
    Miller, F.
    Persson, I.
    Meulien, D.
    EUROPEAN PSYCHIATRY, 2007, 22 : S132 - S132
  • [35] Safety and efficacy of long-acting risperidone in schizophrenia: A 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics
    Lindenmayer, JP
    Eerdekens, E
    Berry, SA
    Eerdekens, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (08) : 1084 - 1089
  • [36] Switching to quetiapine from other atypical antipsychotics improves sexual dysfunction: Preliminary results of an open-label study
    Bouchard, RH
    Demers, MF
    Roy, MA
    Almeras, N
    Villeneuve, J
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 180 - 180
  • [37] A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder
    Khan, Arifulla
    Joyce, Mark
    Atkinson, Sarah
    Eggens, Ivan
    Baldytcheva, Irina
    Eriksson, Hans
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (04) : 418 - 428
  • [38] Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes
    Schwartz, S
    Fonseca, V
    Berner, B
    Cramer, M
    Chiang, YK
    Lewin, A
    DIABETES CARE, 2006, 29 (04) : 759 - 764
  • [39] Long-term safety and efficacy of a once-daily formulation of alfuzosin 10 mg in patients with symptomatic benign prostatic hyperplasia: Open-label extension study
    van Kerrebroeck, P
    Jardin, A
    van Cangh, P
    Laval, KU
    EUROPEAN UROLOGY, 2002, 41 (01) : 54 - 60
  • [40] Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease
    Hauser, Robert A.
    Reichmann, Heinz
    Lew, Mark
    Asgharian, Afsaneh
    Makumi, Clare
    Shulman, Kenneth J.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 (05) : 246 - 253
12345